Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways

被引:97
作者
Ricciardolo, FLM
Steinhoff, M
Amadesi, S
Guerrini, R
Tognetto, M
Trevisani, M
Creminon, C
Bertrand, C
Bunnett, NW
Fabbri, LM
Salvadori, S
Geppetti, P
机构
[1] Univ Ferrara, Pharmacol Unit, Dept Expt & Clin Med, I-44100 Ferrara, Italy
[2] Univ Ferrara, Dept Pharmaceut Chem, I-44100 Ferrara, Italy
[3] CEA Saclay, DRM, SPI, CEA, F-91191 Gif Sur Yvette, France
[4] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA
[5] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[6] Roche Biosci, Inflammatory Dis Unit, Palo Alto, CA USA
关键词
D O I
10.1164/ajrccm.161.5.9907133
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The protease activated receptor-2 (PAR-2) belongs to a family of G-protein-coupled receptors that are activated by proteolysis. Trypsin cleaves PAR-2 exposing an N-terminal tethered ligand (SLIGRL) that activates the receptor. Messenger RNA (mRNA) for PAR-2 was found in guinea pig airway tissue by reverse transcription-polymerase chain reaction, and PAR-2 was found by immunohistochemistry in airway epithelial and smooth-muscle cells. In anesthetized guinea pigs, trypsin and SLIGRL-NH2 (given intratracheally or intravenously) caused a bronchoconstriction that was inhibited by the combination of tachykinin-NK1 and -NK2 receptor antagonists and was potentiated by inhibition of nitric oxide synthase (NOS). Trypsin and SLIGRL-NH2 relaxed isolated trachea and main bronchi, and contracted intrapulmonary bronchi. Relaxation of main bronchi was abolished or reversed to contraction by removal of epithelium, administration of indomethacin, and NOS inhibition. PAR-1, PAR-3, and PAR-4 were not involved in the bronchomotor action of either trypsin or SLIGRL-NH2, because ligands of these receptors were inactive either in vitro or in vivo, and because thrombin (a PAR-1 and PAR-3 agonist) did not show cross-desensitization with PAR-2 agonists in vivo. Thus, we have localized PAR-2 to the guinea-pig airways, and have shown that activation of PAR-2 causes multiple motor effects in these airways, including in vivo bronchoconstriction, which is In part mediated by a neural mechanism.
引用
收藏
页码:1672 / 1680
页数:9
相关论文
共 36 条
[1]   The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough [J].
Advenier, C ;
Lagente, V ;
Boichot, E .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (08) :1892-1906
[2]   CAPSAICIN INCREASES AIR-FLOW RESISTANCE IN GUINEA-PIGS IN-VIVO BY ACTIVATING BOTH NK(2) AND NK(1) TACHYKININ RECEPTORS [J].
BERTRAND, C ;
NADEL, JA ;
GRAF, PD ;
GEPPETTI, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (04) :909-914
[3]  
Bohm SK, 1996, BIOCHEM J, V314, P1009
[4]   Bronchoconstrictor effect of thrombin and thrombin receptor activating peptide in guinea-pigs in vivo [J].
Cicala, C ;
Bucci, M ;
De Dominicis, G ;
Harriot, P ;
Sorrentino, L ;
Cirino, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (02) :478-484
[5]   TRYPTASE INHIBITORS BLOCK ALLERGEN-INDUCED AIRWAY AND INFLAMMATORY RESPONSES IN ALLERGIC SHEEP [J].
CLARK, JM ;
ABRAHAM, WM ;
FISHMAN, CE ;
FORTEZA, R ;
AHMED, A ;
CORTES, A ;
WARNE, RL ;
MOORE, WR ;
TANAKA, RD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (06) :2076-2083
[6]   A protective role for protease-activated receptors in the airways [J].
Cocks, TM ;
Fong, B ;
Chow, JM ;
Anderson, GP ;
Frauman, AG ;
Goldie, RG ;
Henry, PJ ;
Carr, MJ ;
Hamilton, JR ;
Moffatt, JD .
NATURE, 1999, 398 (6723) :156-160
[7]   Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor [J].
Corvera, CU ;
Dery, O ;
McConalogue, K ;
Bohm, SK ;
Khitin, LM ;
Caughey, GH ;
Payan, DG ;
Bunnett, NW .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1383-1393
[8]  
D'Andrea MR, 1998, J HISTOCHEM CYTOCHEM, V46, P157
[9]   Proteinase-activated receptors:: novel mechanisms of signaling by serine proteases [J].
Déry, O ;
Corvera, CU ;
Steinhoff, M ;
Bunnett, NW .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 274 (06) :C1429-C1452
[10]   IN-VITRO AND IN-VIVO BIOLOGICAL-ACTIVITIES OF SR140333, A NOVEL POTENT NONPEPTIDE TACHYKININ NK1, RECEPTOR ANTAGONIST [J].
EMONDSALT, X ;
DOUTREMEPUICH, JD ;
HEAULME, M ;
NELIAT, G ;
SANTUCCI, V ;
STEINBERG, R ;
VILAIN, P ;
BICHON, D ;
DUCOUX, JP ;
PROIETTO, V ;
VANBROECK, D ;
SOUBRIE, P ;
LEFUR, G ;
BRELIERE, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 250 (03) :403-413